Article
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions.
Endocrinology - 1 Sept 2007
Jagla Monika, Fève Marie, Kessler Pascal, Lapouge Gaëlle, Erdmann Eva, Serra Sebastian, Bergerat Jean-Pierre, Céraline Jocelyn
Abstract excerpt
The androgen receptor (AR) is a ligand-activated transcription factor that displays genomic actions characterized by binding to androgen-response elements in the promoter of target genes as well as nongenomic actions that do not require nuclear translocation and DNA binding. In this study, we rep...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
